EthanChase2184

$ESPR - Long Esperion Therapeutics

EthanChase2184 업데이트됨   
NASDAQ:ESPR   Esperion Therapeutics, Inc.
2
Potential long.

Reported solid phase 1 and phase 2 results for its drug Bempedoic Acid.

Amgen is soon releasing results from a similar drug; if results are promising, $ESPR could trend up.

Also forming cup and handle pattern.
코멘트:
Watch for the break over $12.00
코멘트:
DISCLAIMERS:
**The trades seen in this post are in no way intended to be used as advice or guidance for your own trading. These posts are intended for an educational and entertainment purpose only. Day trading and investing in the stock market in general is high risk. Please do not take any comments as direction in trading your own account, and as such, I will not be held liable by any financial losses in your account. **

**I am not a financial advisor. The ideas presented in this post are personal opinions and for entertainment purposes only.**

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.